■
農藥一路發20056期 (2001/7/10) 主編: 方麗萍 www.ag168.com
主題:
安萬特宣佈與拜耳商討被收購事宜
今天安萬特及先靈正式公佈,
跟著這數星期該公司只與拜耳繼續商討安萬特農業科技被收購事宜.
安萬特持股76%,
先靈則24%. 在2000年11月安萬特已決定將其農業科技部門獨立,
並於2001年底完成.
繼而在衡量其股價,
今決定將該部門賣出.
因拜耳在競標中出價最高,
且鑑於財務及社會方面的考量,
拜耳是最有合作可能的伙伴.
安萬特農業科技是一以農作物保護為主的公司,
專於研發及市場革新以合乎現在農業所需.
2000年之營業額為40億,
員工共15,300人, 分佈於120個國家.
該公司於7月10日之公佈原文如下:
--------------------------------------
Aventis SA Press Release 07-10-2001
Aventis CropScience negotiations to be continued exclusively with Bayer AG
Aventis considers trade sale as most value-enhancing option
Strasbourg, France - Aventis and Schering AG agreed and announced today
that for the weeks to come the negotiation process concerning the potential
divestment of Aventis CropScience will be continued exclusively with Bayer
AG. Aventis holds a 76 percent interest in the crop protection and
production business, while Schering AG, Berlin, holds 24 percent. In
November 2000, Aventis announced its intention to divest Aventis
CropScience by the end of 2001 in order to focus on its pharmaceutical
business. After reviewing different divestment options, Aventis has now
decided on a trade sale, which it considers the most value-enhancing
option. After analyzing first bids from several companies, Bayer has
emerged as the most-promising partner - financially and socially.
The decision to continue the negotiations exclusively with Bayer AG does
not constitute any legally binding agreement between the involved
companies. As the negotiations evolve, all legally required information and
consultation procedures with the relevant employee representative bodies as
well as with the relevant corporate governance bodies and external
authorities will be adhered to. The implementation of any disposition of
CropScience by Aventis is subject to negotiation and execution of a
definitive agreement and receipt of all applicable regulatory approvals.
Aventis CropScience is a major crop protection and crop production company
focusing on researching, developing and marketing innovative solutions that
meet the needs of today's farming: healthy crops, increased yields,
improved crop and food quality. With ? 4 billion sales in 2000, Aventis
CropScience employs about 15,300 people in more than 120 countries world-
wide.
Aventis (NYSE: AVE) is dedicated to improving life through the discovery
and development of innovative products. In 2000, Aventis generated group
sales of ? 22.3 billion and employed around 92,500 people in its Pharma and
Agriculture businesses. Aventis was launched in December 1999 through the
merger of Hoechst AG of Germany and Rhône-Poulenc SA of France. Corporate
headquarters are in Strasbourg, France. For more information, please visit:
www.aventis.com
Statements in this news release other than historical information are
forward-looking statements subject to risks and uncertainties. Actual
results could differ materially depending on factors such as the
availability of resources, the timing and effects of regulatory actions,
the strength of competition, the outcome of litigation and the
effectiveness of patent protection. Additional information regarding risks
and uncertainties is set forth in the current Annual Report on Form 20-F
of Aventis on file with the Securities and Exchange Commission.
■
http:\\www.ag168.com|
玉田地有限公司|
電話:
0919278319| 傳真:
02-27644109| rdai@ms1.hinet.net
■查閱其他電子報